ESR1 and breast cancer: Breast cancer tissue specimens typically exhibit positive results for CK7, GATA-3, GCDFP15, and SCGB2A2, with approximately 30% of OBCs testing positive for estrogen receptor (ER) and progesterone receptor (PR), while 40% are negative [7, 8].